- Home
- FNKO vs FDMT Comparison
FNKO vs FDMT Comparison
Compare FNKO & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FNKO
- FDMT
- Stock Information
- Founded
- FNKO 2017
- FDMT 2013
- Country
- FNKO United States
- FDMT United States
- Employees
- FNKO N/A
- FDMT N/A
- Industry
- FNKO Recreational Games/Products/Toys
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- FNKO Consumer Discretionary
- FDMT Health Care
- Exchange
- FNKO Nasdaq
- FDMT Nasdaq
- Market Cap
- FNKO 170.7M
- FDMT 192.2M
- IPO Year
- FNKO 2017
- FDMT 2020
- Fundamental
- Price
- FNKO $3.37
- FDMT $7.09
- Analyst Decision
- FNKO Strong Buy
- FDMT Buy
- Analyst Count
- FNKO 5
- FDMT 9
- Target Price
- FNKO $8.70
- FDMT $30.63
- AVG Volume (30 Days)
- FNKO 1.8M
- FDMT 728.8K
- Earning Date
- FNKO 11-06-2025
- FDMT 08-11-2025
- Dividend Yield
- FNKO N/A
- FDMT N/A
- EPS Growth
- FNKO N/A
- FDMT N/A
- EPS
- FNKO N/A
- FDMT N/A
- Revenue
- FNKO $970,702,000.00
- FDMT $33,000.00
- Revenue This Year
- FNKO N/A
- FDMT $9,921.62
- Revenue Next Year
- FNKO $10.55
- FDMT N/A
- P/E Ratio
- FNKO N/A
- FDMT N/A
- Revenue Growth
- FNKO N/A
- FDMT N/A
- 52 Week Low
- FNKO $2.22
- FDMT $2.24
- 52 Week High
- FNKO $14.65
- FDMT $17.41
- Technical
- Relative Strength Index (RSI)
- FNKO 50.22
- FDMT 62.39
- Support Level
- FNKO $3.18
- FDMT $6.09
- Resistance Level
- FNKO $3.40
- FDMT $7.33
- Average True Range (ATR)
- FNKO 0.22
- FDMT 0.50
- MACD
- FNKO 0.09
- FDMT -0.03
- Stochastic Oscillator
- FNKO 79.29
- FDMT 80.42
About FNKO Funko Inc.
Funko Inc is an USA based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.